Expression and potential immune involvement of cuproptosis in kidney renal clear cell carcinoma

被引:25
作者
Liu, Hengrui [1 ]
机构
[1] Tianjin Yinuo Biomed Co Ltd, 1 Shuchang Pk,Wanxin St, Tianjin, Peoples R China
关键词
Cuproptosis; KIRC; Genes; Immunotherapy;
D O I
10.1016/j.cancergen.2023.03.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cuproptosis is a newly identified programmed cell death pathway mediated by intracellular free copper. Cuproptosis genes were studied in this study for a better insight into the role of cuproptosis in cancers. The analysis identified kidney renal clear cell carcinoma (KIRC) as a cancer type most likely to be affected by cuproptosis. This study analyzed the multi-omic data to explore the cancer-noncancer expression pattern and potential immune involvement of the cuproptosis pathway in KIRC. This study clustered the TCGA KIRC samples based on the gene set of 12 cuproptosis genes to study the role of cuproptosis in the KIRC immune microenvironment and found the potential value of cuproptosis signature for immunotherapy prognosis. This study concluded that cuproptosis might affect KIRC and had potential application value in immune therapy. Hopefully, this study can contribute to the application of cuproptosis in the clinical therapy of KIRC.& COPY; 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:21 / 25
页数:5
相关论文
共 50 条
  • [41] Circadian clock is associated with tumor microenvironment in kidney renal clear cell carcinoma
    Zhou, Liangcheng
    Luo, Zhili
    Li, Zuwei
    Huang, Qinying
    AGING-US, 2020, 12 (14): : 14620 - 14632
  • [42] Characterization and verification of MMP family members as potential biomarkers in kidney clear cell renal carcinoma
    Zhao, Tianyu
    Li, Xue
    Li, Mingfeng
    Jamil, Muhammad
    Zhang, Jingyu
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (09): : 3941 - 3962
  • [43] Identification of the Prognosis Value and Potential Mechanism of Immune Checkpoints in Renal Clear Cell Carcinoma Microenvironment
    Liao, Guodong
    Wang, Ping
    Wang, Yuyong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [44] Multi-omics pan-cancer study of cuproptosis core gene FDX1 and its role in kidney renal clear cell carcinoma
    Xu, Jiahao
    Hu, Zhengang
    Cao, Hui
    Zhang, Hao
    Luo, Peng
    Zhang, Jian
    Wang, Xiaoyan
    Cheng, Quan
    Li, Jingbo
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [45] Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma
    Hang Xu
    Xiaonan Zheng
    Shiyu Zhang
    Xianyanling Yi
    Tianyi Zhang
    Qiang Wei
    Hong Li
    Jianzhong Ai
    Molecular Cancer, 20
  • [46] Prognostic Impact of MITD1 and Associates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma
    Chen, Chujie
    Sheng, Yiyu
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [47] Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma
    Xu, Hang
    Zheng, Xiaonan
    Zhang, Shiyu
    Yi, Xianyanling
    Zhang, Tianyi
    Wei, Qiang
    Li, Hong
    Ai, Jianzhong
    MOLECULAR CANCER, 2021, 20 (01)
  • [48] Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma
    Ghatalia, Pooja
    Gordetsky, Jennifer
    Kuo, Fengshen
    Dulaimi, Essel
    Cai, Kathy Q.
    Deyarajan, Karthik
    Bae, Sejong
    Naik, Gurudatta
    Chan, Timothy A.
    Uzzo, Robert
    Hakimi, A. Ari
    Sonpavde, Guru
    Plimack, Elizabeth
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [49] Adrenomedullin/FOXO3 enhances sunitinib resistance in clear cell renal cell carcinoma by inhibiting FDX1 expression and cuproptosis
    Wang, Xin
    Jia, Jiang-Hua
    Zhang, Ming
    Meng, Qing-Song
    Yan, Bo-Wen
    Ma, Zi-Yue
    Wang, Dong-Bin
    FASEB JOURNAL, 2023, 37 (10)
  • [50] Comprehensive analysis of LAMC1 expression and prognostic value in kidney renal papillary cell carcinoma and clear cell carcinoma
    Bai, Jianrong
    Zheng, Axiu
    Ha, Yanping
    Xu, Xiaoqing
    Yu, Yaping
    Lu, Yanda
    Zheng, Shaojiang
    Shen, Zhihua
    Luo, Botao
    Jie, Wei
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9